Skip to main content
Premium Trial:

Request an Annual Quote

LION Bioscience to Join Automation Partnership In Mapping Tools Dev't

Premium

HEIDELBERG--LION Bioscience, a bioinformatics company here, announced that, in partnership with the Automation Partnership, it will automate membrane filter processing and DNA hybridization, key steps in genome mapping. LION said its success in the area of microbial genomics research has led to the need to increase its capacity and add a further accelerated genome mapping process in the midterm future.

Automation Partnership is a UK-based provider of advanced automated tools for life sciences research, from drug discovery and genomics processing to production and packaging. LION's collaboration covers a multiphase project in which the partners will first develop new techniques to make the complex steps of the research easier to automate. Later phases will see the design and implementation of enhanced automated systems at LION to meet the demands of its life sciences customers.

Patrik Scholler, LION's vice-president of technologies, remarked that "manual processing methods are failing to keep pace with industry's need for reproducible quality, large scale, and higher throughput."

"Automation will match and exceed the manual methods, speeding up the gene and drug discovery cycle and therefore the time to market for new products," he concluded.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.